Ameriprise’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-307,087
| Closed | -$3.44M | – | 3802 |
|
|
2017
Q3 | $3.44M | Buy |
307,087
+24,685
| +9% | +$276K | ﹤0.01% | 2336 |
|
|
2017
Q2 | $3.11M | Sell |
282,402
-7,215
| -2% | -$79.4K | ﹤0.01% | 2383 |
|
|
2017
Q1 | $2.84M | Buy |
289,617
+13,470
| +5% | +$132K | ﹤0.01% | 2415 |
|
|
2016
Q4 | $2.98M | Buy |
276,147
+29,262
| +12% | +$316K | ﹤0.01% | 2421 |
|
|
2016
Q3 | $2.53M | Buy |
246,885
+7,250
| +3% | +$74.3K | ﹤0.01% | 2435 |
|
|
2016
Q2 | $3.13M | Buy |
+239,635
| New | +$3.13M | ﹤0.01% | 2270 |
|
|
2014
Q4 | – | Sell |
-888
| Closed | -$7K | – | 4889 |
|
|
2014
Q3 | $7K | Buy |
888
+148
| +20% | +$1.17K | ﹤0.01% | 4987 |
|
|
2014
Q2 | $4K | Sell |
740
-16,060
| -96% | -$86.8K | ﹤0.01% | 5012 |
|
|
2014
Q1 | $77K | Sell |
16,800
-35,840
| -68% | -$164K | ﹤0.01% | 3616 |
|
|
2013
Q4 | $265K | Sell |
52,640
-28,661
| -35% | -$144K | ﹤0.01% | 3046 |
|
|
2013
Q3 | $412K | Buy |
81,301
+230
| +0.3% | +$1.17K | ﹤0.01% | 2943 |
|
|
2013
Q2 | $402K | Buy |
+81,071
| New | +$402K | ﹤0.01% | 2880 |
|